Back
Corporate News
BAFNA Pharmaceuticals to review quarterly results at board meeting on August 11, 2026
05-Aug-2026, 07:09
BAFNA PHARMACEUTICALS LIMITED will hold a board meeting on August 11, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026, and the trading window for designated persons and their immediate relatives will remain closed from July 1, 2026, to August 13, 2026.
BAFNA PHARMACEUTICALS LIMITED will hold a board meeting on August 11, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026, and the trading window for designated persons and their immediate relatives will remain closed from July 1, 2026, to August 13, 2026.